TARO: Taro Pharmaceutical Industries Ltd. - Summary | Jitta

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

Price
$103.91
Loss Chance
41.6%
6.15JITTA SCORE
12.80%Above Jitta Line
Jitta Ranking
20 / 811
449 / 4,749
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (28)
Recent Business Performance (75)
Financial Strength (100)
Return to Shareholders (74)
Competitive Advantage (97)
Jitta Signs
Debt LevelLow Long Term Debt
Share RepurchaseEvery Year
CapExVery Low
Revenue and EarningRevenue decline from 2015-2018
Operating MarginDeclined
Recent Business PerformanceEarning decline 53.46% in the last year
Key Stats
Jitta Score
Jitta Line
6.15
12.80%
2.38
0.68%
Pharmaceuticals
2.05
100.00%
2.20
6.72%
4.20
405.16%
COMPANY DESCRIPTION
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. It offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Zrt.